YOU HAVE 0 SLIDES IN YOUR BASKET

Search results

This search includes:

Content Areas

Brand Expand: Brand Awareness; Brand Favorability; Favorability drivers; Building global relationships; Credibility in the Boardroom; Industry specialist; Practical and pragmatic; Project management

Budgets and pricing Expand: Hourly rates; In-house legal spend; Number of lawyers; Pricing model; Remuneration; Spend on outside counsel; Spend on international counsel; Spend proportion on work; Spending less; Spending more; Typical spend

Client experience Expand: Diversity; Formal client feedback; Improving satisfaction; Law firm performance; Losing business; Overall satisfaction; Winning new business

International needs Expand: Countries with legal needs; Firms most used; Number of countries; International office; International work type needs

Legal market trends Expand: Number of matters; Risks; Industry challenges; Business challenges; Department goals; Key metrics; Alternative service providers; Legal systems; Alumni; Partner changes; Working with the Board; Specialist roles

Recommendations Expand: Advocacy; Reasons for recommending firms; Improving recommendations chances; Reasons for not recommending firms

Work type considerations Expand: Top-level litigation; Top-level M&A; Multi-jurisdictional litigation; Multi-jurisdictional deals; Regulatory; Main work type; Intellectual Property

Demand and opportunities Expand: Work type demand; Most used high value; Delivering more value; Loyalty; Mergers; Number of law firms used; Firm type preference; Independent firm usage

Future of the legal market Expand: Firm innovation

Pitching and communications Expand: Formal pitching; Best pitch; Law firm advertising; Law firm marketing; Online technologies; News sources

2013

2014

2015

2016

Global Elite ($1bn+ revenue)

US Expand: Northeast; South; West; Midwest

UK Expand: London

Canada

Asia Pacific Expand: China; Japan; Australia; India; Singapore; South Korea

Mainland Europe Expand: Central Eastern Europe (CEE); France; Germany; Russia; Italy; Spain; Netherlands

Latin America Expand: Brazil; Mexico

Middle East (inc. UAE)Expand: UAE

Africa

Full Global

General industries Expand: Automotive; Business services; Manufacturing; Pharmaceuticals/Bioscience; Pharmaceuticals/Bioscience/Healthcare

Energy Expand: Energy/Utilities/Natural resources; Energy/Utilities; Natural resources

Financial institutions and investors Expand: Banking; Financial services; Insurance; Investment

Consumer/Food/Health Expand: Retail/Wholesale; Healthcare; Food/Farming/Fisheries; Hospitality/Leisure

Technology/Media/Telecoms

Real estate/Construction/Engineering Expand: Construction; Real estate; Engineering

Transport/Logistics/Distribution

Government/Public Sector/Not-For-Profit

GenderExpand: Female; Male

AgeExpand: Under 40; 40-50; Over 50

RoleExpand: Chief Legal Role; Assistant GC/Deputy GC; Chief counsel for a particular practice area; Chief Role (CFO/COO); Other legal role

International legal needsExpand: International buyer; Domestic buyer; Legal need in 10+ countries

Org. RevenueExpand: $50m-$1bn; $1bn-$6bn; Over $6bn

Legal spendExpand: More than $5m

SEARCH

Clear Selection

Improving recommendation chances

Sharplegal Global Elite 2013 - Pharmaceuticals/Bioscience

This slide shows the main drivers for clients who are highly likely to recommend firms they work wit...
Improving recommendation chances

Sharplegal Global Elite 2013 - Pharmaceuticals/Bioscience/Healthcare (COMBINED)

This slide shows the main drivers for clients who are highly likely to recommend firms they work wit...
Improving recommendation chances

Sharplegal US 2013 - Pharmaceuticals / Bioscience / Healthcare (COMBINED)

This slide shows the main drivers for clients who are highly likely to recommend firms they work wit...
Likelihood to recommend

Sharplegal Full Global 2014 - Pharmaceuticals/Bioscience

This slide shows how likely clients are to recommend various law firms they have used. Respondents a...
Likelihood to recommend

Sharplegal Full Global 2015 - Pharmaceuticals/Bioscience

This slide shows how likely clients are to recommend various law firms they have used. Respondents a...
Likelihood to recommend

Sharplegal Full Global 2016 - Pharmaceuticals/Bioscience

This slide shows how likely clients are to recommend various law firms they have used. Respondents a...
Likelihood to recommend

Sharplegal Global Elite 2013 - Pharmaceuticals/Bioscience

This slide shows how likely clients are to recommend various law firms they have used. Respondents a...
Likelihood to recommend

Sharplegal Global Elite 2013 - Pharmaceuticals/Bioscience/Healthcare (COMBINED)

This slide shows how likely clients are to recommend various law firms they have used. Respondents a...
Likelihood to recommend

Sharplegal Global Elite 2014 - Pharmaceuticals/Bioscience

This slide shows how likely clients are to recommend various law firms they have used. Respondents a...
Likelihood to recommend

Sharplegal Global Elite 2015 - Pharmaceuticals/Bioscience

This slide shows how likely clients are to recommend various law firms they have used. Respondents a...
Likelihood to recommend

Sharplegal US 2013 - Pharmaceuticals/Bioscience/Healthcare (COMBINED)

This slide shows how likely clients are to recommend various law firms they have used. Respondents a...
Likelihood to recommend

Sharplegal Global Elite 2016 - Pharmaceuticals/Bioscience

This slide shows how likely clients are to recommend various law firms they have used. Respondents a...
Reasons for not recommending firms

Sharplegal Global Elite 2013 - Pharmaceuticals/Bioscience/Healthcare

This slide shows the main drivers for clients who are highly likely to recommend firms they work wit...
Reasons for not recommending firms

Sharplegal Global Elite 2013 - Pharmaceuticals/Bioscience

This slide shows the main drivers for clients who are highly likely to recommend firms they work wit...
Reasons for not recommending firms

Sharplegal US 2013 - Pharmaceuticals/Bioscience/Healthcare

This slide shows the main drivers for clients who are highly likely to recommend firms they work wit...
Reasons for recommending firms

Sharplegal Global Elite 2013 - Pharmaceuticals/Bioscience/Healthcare (COMBINED)

This slide shows the likelihood of clients recommending firms they work with, and the drivers for th...
Reasons for recommending firms

Sharplegal Global Elite 2013 - Pharmaceuticals/Bioscience

This slide shows the likelihood of clients recommending firms they work with, and the drivers for th...
Reasons for recommending firms

Sharplegal US 2013 - Pharmaceuticals/Bioscience/Healthcare (COMBINED)

This slide shows the likelihood of clients recommending firms they work with, and the drivers for th...
Reasons for recommending firms

Sharplegal Full Global 2016 - Pharmaceuticals/Bioscience

This slide shows the main drivers for clients who are highly likely to recommend firms they work wit...
Reasons for recommending firms

Sharplegal Full Global 2016 - Pharmaceuticals/Bioscience

This slide shows the main drivers for clients who are highly likely to recommend firms they work wit...

Feedback Let us know what can be improved to ensure the returned analysis slides are supporting your needs